Lexeo Therapeutics, Inc.
LXEO
$8.66
$0.344.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.28M | -26.10M | -32.66M | -25.92M | -29.49M |
| Total Depreciation and Amortization | 530.00K | 510.00K | 501.00K | 521.00K | 509.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.71M | -285.00K | 3.71M | 3.48M | 3.79M |
| Change in Net Operating Assets | -12.51M | -1.34M | 6.73M | -6.41M | 7.38M |
| Cash from Operations | -29.55M | -27.22M | -21.72M | -28.33M | -17.81M |
| Capital Expenditure | -289.00K | -108.00K | -- | 0.00 | -83.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 35.30M | -39.07M | 15.60M | -93.58M | 0.00 |
| Cash from Investing | 35.01M | -39.17M | 15.60M | -93.58M | -83.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -83.00K | -122.00K | -159.00K | -116.00K | -111.00K |
| Issuance of Common Stock | 135.00K | 80.00M | 170.00K | 6.31M | 39.00K |
| Repurchase of Common Stock | -- | -- | -- | -4.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -6.92M | -- | -6.29M | 0.00 |
| Cash from Financing | 52.00K | 72.96M | 11.00K | -97.00K | -72.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.52M | 6.57M | -6.11M | -122.01M | -17.96M |